Joshua M. Eizen, See Remarks at AN2 Therapeutics, Inc. (ANTX), sold 5,945 shares at $4.17 ($25K) on 2026-07-08, disclosed to the SEC on 2026-07-10.
Open-market sale of $25k ANTX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANTX | SELL | 2025-01-07 | $13K | — | Filing → |